Transient Ischemic Attack News and Research

RSS

A transient ischemic attack (TIA) is a transient stroke that lasts only a few minutes. It occurs when the blood supply to part of the brain is briefly interrupted. TIA symptoms, which usually occur suddenly, are similar to those of stroke but do not last as long. Most symptoms of a TIA disappear within an hour, although they may persist for up to 24 hours. Symptoms can include: numbness or weakness in the face, arm, or leg, especially on one side of the body; confusion or difficulty in talking or understanding speech; trouble seeing in one or both eyes; and difficulty with walking, dizziness, or loss of balance and coordination.

Researchers develop new scoring method to predict bleeding risk after stroke

A new scoring method may help predict who is at high risk of serious bleeding after a stroke, according to a study published in the August 2, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

2 Aug 2017

Indefinite NHS England 'evaluation process' denies access to life-saving treatment for high risk patients

Arrhythmia Alliance is calling on NHS England to reconsider its ‘Commissioning through Evaluation’ (CtE) process, which has left hundreds of patients with AF (Atrial Fibrillation) at serious risk of suffering a debilitating or life-threatening AF-related stroke.

28 Jul 2017

Study finds increased risk of death, heart attack in people who survive stroke without complications

People who survive a stroke or a mini-stroke without early complications have an increased risk of death, another stroke or heart attack (myocardial infarction) for at least 5 years following the initial stroke, found a new study published in CMAJ.

24 Jul 2017

Proton pump inhibitors do not increase risk for dementia or Alzheimer's disease

Proton pump inhibitors (PPIs) are medications used to treat digestive problems such as ulcers and reflux disease by reducing the body's production of the acid that helps us digest food.

22 Jun 2017

Survey: One in three American adults could have experienced sign of warning stroke

About one in three American adults experienced a symptom consistent with a warning or "mini" stroke, but almost none - 3 percent - took the recommended action, according to a new survey from the American Heart Association/American Stroke Association.

2 May 2017

AATS consensus statement offers guidance on surgical ablation for treatment of atrial fibrillation

Atrial fibrillation, an irregular heart rhythm that can cause an increased risk of stroke, affects approximately 2.2 million Americans each year. According to projections, that number is set to double in the next 25 years.

19 Apr 2017

CPAP treatment offers no cardiovascular benefit in OSA patients with heart disease risk

More than 3 years of nightly treatment with a continuous positive airway pressure (CPAP) machine did not reduce cardiovascular risk more than usual care among patients with cardiovascular disease and obstructive sleep apnea (OSA).

30 Aug 2016

New review finds link between sleep disorders and stroke risk

There is growing evidence that sleep disorders like insomnia and sleep apnea are related to stroke risk and recovery from stroke, according to a recent literature review.

4 Aug 2016

Updated AAN guidelines state closure not recommended for individuals with stroke and heart defect

An updated recommendation from the American Academy of Neurology states that catheter-based closure should not be routinely recommended for people who have had a stroke and also have a heart defect called a patent foramen ovale (PFO), a channel between the top two chambers in the heart.

28 Jul 2016

Study explores differences in neuroimaging utilization for stroke from population perspective

A person is admitted to the hospital with a stroke, but not much is known about whether or not that patient will undergo neuroimaging.

26 May 2016

Mini-stroke should immediately be treated with aspirin, recommend researchers

Taking aspirin immediately after experiencing stroke-like symptoms could significantly reduce the risk of a major stroke occurring in the next few days, according to a study published in The Lancet.

19 May 2016

Important signs, symptoms of stroke that everyone should know

Almost 795,000 Americans suffer from stroke each year, 130,000 which are fatal, making stroke the fifth leading cause of death in the United States.

13 May 2016

Novel anticoagulants on ‘as-needed basis’ could be safe alternative to lowering stroke risk

Patients with atrial fibrillation (AF), a rapid irregular heartbeat caused by pooling blood in the heart which can lead to heart failure and stroke, are often treated with an ablation, a minimally invasive procedure used to remove the tissue which causes the pooled blood.

9 May 2016

Structured transitional stroke care could decrease hospital readmission rates

A transitional stroke clinic developed by doctors and nurse practitioners at Wake Forest Baptist Medical Center reduced 30-day readmission rates by 48 percent, according to a study published in the April 28 online issue of the journal Stroke.

29 Apr 2016

Stenting and surgery equally effective at lowering long-term risk of stroke

Investigators for the Carotid Revascularization Endarterectomy versus Stenting Trial found that stenting and surgery are equally effective at lowering the long-term risk of stroke from a narrowed carotid artery, according to a study published today in The New England Journal of Medicine.

22 Feb 2016

Pioglitazone drug may prevent recurrent stroke and heart attacks

Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance but without diabetes.

18 Feb 2016

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

New Haven Pharmaceuticals, Inc. today announced the availability by prescription of DURLAZA, the first and only 24-hour, extended-release aspirin capsules (162.5mg) approved by the U.S. Food and Drug Administration (FDA) for the secondary prevention of stroke and acute cardiac events, including myocardial infarction (heart attack) in high-risk cardiovascular patients.

7 Jan 2016

New MRI-based technology could help identify patients at risk of recurrent stroke

Patients who have had a stroke in the back of the brain are at greater risk of having another within two years if blood flow to the region is diminished, according to results of a multicenter study led by researchers at the University of Illinois at Chicago.

22 Dec 2015

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals, Inc. today announced new study data that shows the company's FDA-approved drug DURLAZA delivers sustained antiplatelet control for a full 24-hour period in high-risk patients.

10 Nov 2015

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced results from PMSS (Post-Marketing Safety Surveillance) and XANTUS (XARELTO for Prevention of Stroke in Patients with Atrial Fibrillation), their landmark real-world studies evaluating the safety of XARELTO in people with non-valvular atrial fibrillation (NVAF).

1 Sep 2015